Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Open in API
Filings indexed 512 across all filing types
Latest filing 2021-11-16 Proxy Solicitation & In…
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
Proxy Solicitation & Information Statement 2021
Proxy Solicitation & Information Statement
2021-11-16 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Q3 2021
2021-11-15 English
Proxy Solicitation & Information Statement 2021
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes detailed information about a Special Meeting of Stockholders, including the date, voting instructions, proposals to be voted on, and other related information. The document is not an announcement of a report, nor is it a financial report or earnings release. It is a solicitation of proxies and information provided to shareholders to inform and request votes for a meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length and content confirm it is the full proxy statement, not just a notice or announcement.
2021-11-05 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content describes an amendment to the company's bylaws regarding quorum requirements for stockholder meetings. It includes details about the amendment and references an exhibit containing the amendment text. There are no financial statements or detailed financial data present. The document is a regulatory announcement of a corporate governance change, specifically an amendment to bylaws, which fits best under Regulatory Filings (RNS) as it does not fall under more specific categories like Board/Management Information (MANG) which typically covers changes in personnel rather than bylaws amendments. The document length is about 5,045 characters, which is not a brief announcement but a full current report. However, since it is a Form 8-K reporting a corporate governance amendment and not a full report or financial statement, the best classification is Regulatory Filings (RNS).
2021-11-04 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text includes standard Form 8-K headings, SEC references, and mentions a press release attached as an exhibit. The document length is 3298 characters, which is relatively short and primarily serves as an announcement of an event (Regulation FD Disclosure) rather than a full report containing financial data or detailed analysis. Therefore, it is not an Annual Report, Earnings Release, or Interim Report. It is also not a certification or officer attestation. Given these factors, the document fits best into the Regulatory Filings (RNS) category, which is the fallback for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2021-10-12 English
Capital/Financing Update 2021
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes detailed information about the securities to be registered, the plan under which they are issued, and references to other SEC filings. This type of filing is related to capital raising activities through employee stock plans and is not a financial report, earnings release, or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or certification.
2021-09-02 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.